# Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea

> **NCT02538562** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1695 (actual)

## Conditions studied

- Gastric Cancer
- Gastroesophageal Junction Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02538562
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-11
- **Primary completion:** 2013-04-19
- **Final completion:** 2013-04-19
- **Target enrollment:** 1695 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538562, "Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02538562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*